(Q34399554)

1 August 2017

1 reference

title

Matrix metalloproteinase inhibition and the prevention of heart failure (English)

1 reference

1 August 2017

1 reference

Lee RT

1

1 reference

1 August 2017

1 July 2001

1 reference

Trends in Cardiovascular Medicine

1 August 2017

1 reference

1 August 2017

11

1 reference

1 August 2017

5

1 reference

1 August 2017

202-205

1 reference

Prevention of cartilage breakdown by matrix metalloproteinase inhibition--a realistic therapeutic target?

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Disruption of the myocardial extracellular matrix leads to cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900113-X

7 January 2021

10.1016/S1050-1738(01)00113-X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11597832